Amrize AG (AMRZ) Stock Analysis
Is AMRZ a good investment?
Amrize AG (AMRZ) has a Plutrex AI rating of 65.0/100 as of November 12, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Valuation discount with equivalent long-term growth: PEG of 1.62x is 24.6% below the industry average of 2.14x, while 5-year EPS growth of 11.6% essentially matches the industry's 11.4% — investors pay significantly less for the same long-term earnings growth rate compared to peers. Main concern: Unbroken analyst target deterioration with minimal upside: Consensus target has declined in every tracked period ($61.98 → $44.30, -28.6% cumulative) with the stock now only 6.4% below the latest target — the narrowest margin ever tracked; combined with a revenue growth collapse from 8.6% to 2.2%, this dual deterioration makes new entry at $41.63 unfavorable.
Investment Summary
AMRZ is a financially conservative Construction Materials operator trading at $41.63, now materially above the prior entry zone ($34.50–$37.50) established 14 days ago. The stock has rallied +4.0% since the prior report while the analyst consensus target has AGAIN declined from $44.91 to $44.30 (-1.4%), compressing implied upside to only 6.4% — the narrowest margin in the tracking history. The unbroken analyst target deterioration trend ($61.98 → $49.70 → $46.27 → $44.91 → $44.30, cumulative -28.6%) is the single most concerning signal and directly contradicts the news sentiment score of 89.6/100. Key metrics that have moved adversely since the prior report: (1) PEG ratio deteriorated from 1.37x to 1.62x (+17.9%), now only 24.6% below the industry average versus a prior 36.7% discount — the valuation edge is narrowing; (2) Revenue growth collapsed from 8.6% to 2.2% (-74.4%), a severe deterioration that undermines the double-digit EPS growth thesis; (3) FCF declined from $1.32B to $1.08B. Positives include: strong news sentiment (8 of 11 articles positive), aggregates pricing up 6.9% demonstrating pricing power, board share cancellation reducing share count, and $1.3M insider buying signaling management confidence. The company remains financially sound (D/E 0.40x vs. industry 0.655x, FCF $1.08B, $299M cash) with operating margin of 15.7% beating the industry's 14.4%. However, the risk/reward has deteriorated to an unfavorable level for new entrants at current price.
Key Strengths
- Valuation discount with equivalent long-term growth: PEG of 1.62x is 24.6% below the industry average of 2.14x, while 5-year EPS growth of 11.6% essentially matches the industry's 11.4% — investors pay significantly less for the same long-term earnings growth rate compared to peers
- Fortress balance sheet with strategic optionality: D/E of 0.40x (vs. industry 0.655x), FCF of $1.08B, and $299M cash position provide recession resilience, acquisition capacity, and capital return firepower; the board's decision to cancel repurchased shares directly reduces share count, mechanically supporting EPS growth even without revenue acceleration
- Positive pricing environment and insider alignment: Aggregates pricing +6.9% and cement pricing +1.8% demonstrate real pricing power that can partially bridge the revenue growth gap; $1.3M insider buying signals management believes the stock is undervalued at current levels
Key Concerns
- Unbroken analyst target deterioration with minimal upside: Consensus target has declined in every tracked period ($61.98 → $44.30, -28.6% cumulative) with the stock now only 6.4% below the latest target — the narrowest margin ever tracked; combined with a revenue growth collapse from 8.6% to 2.2%, this dual deterioration makes new entry at $41.63 unfavorable
- Revenue growth collapse undermines EPS growth thesis: Revenue growth fell from 8.6% to 2.2% (-74.4% decline in growth rate), making the projected 11.6% 5-year EPS growth rate extremely difficult to sustain organically; PEG expansion from 1.37x to 1.62x (+17.9%) confirms the market is repricing this risk, and the 6.4% implied upside to analyst target provides insufficient margin of safety for new capital
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
AMRZ's fundamentals present a bifurcated picture. VALUATION: P/E of 18.77x is 19.2% below the industry average of 23.22x, and PEG of 1.62x is 24.6% below the industry average of 2.14x — both represent genuine relative value. However, the PEG has worsened from 1.37x (prior) to 1.62x (current), narrowing the discount. PROFITABILITY: Gross margin of 24.9% is severely below the industry's 33.2% (-8.3pp), the most concerning absolute comparison. Operating margin of 15.7% beats industry at 14.4% (+1.3pp), and net margin of 9.9% beats industry at 8.9% (+1.0pp) — AMRZ manages SG&A well but has a structurally inferior gross margin. ROE of 9.5% is 20.6% below the industry average of 12.0%, reflecting the low-leverage structure (D/E 0.40x vs. 0.655x peers). GROWTH: Revenue growth of 2.2% vs. industry 7.9% — AMRZ grows at less than 28% of its sector's pace, the most alarming deterioration since the prior report (from 8.6%). Forward EPS growth of 10.8% (1-year) and 11.6% (5-year) must be questioned: generating 11.6% EPS growth from 2.2% revenue growth requires aggressive margin expansion or buybacks, neither of which is sustainably indefinite. HEALTH: D/E of 0.40x (38.9% below peers), FCF of $1.08B, $299M cash — the balance sheet is a genuine fortress. The FCF/net income divergence implies significant non-cash charges boosting cash generation. ANALYST CONSENSUS: Target of $44.30 implies only 6.4% upside from $41.63 — the narrowest margin in the tracked history, with the target having declined in every single period reviewed.
News Sentiment
Amrize is quietly building its case as a steady-Eddie in the building materials world — but investors expecting fireworks may need to temper their expectations. The company's Q3 2026 earnings call ('What Amrize (AMRZ) Said on Its Q3 Earnings Call' — positive because management highlighted aggregates pricing power of 6.9% and cement pricing gains of 1.8%, demonstrating the company can pass costs to customers even in a sluggish construction environment) painted a picture of a business prioritizing financial discipline over growth. The 'Amrize Reports Third Quarter 2026 Results' headline confirmed solid execution on margins even as revenue growth has slowed dramatically. On the strategic front, Amrize is making a pointed national identity play: 'Amrize Expands Made in Canada Cement Label for Canadian Builders' signals the company is leaning into domestic sourcing narratives — neutral to slightly positive as it differentiates the brand from imported alternatives amid ongoing trade uncertainty. The board's decision to cancel repurchased shares ('Board of Directors intends to cancel repurchased shares') is a shareholder-friendly move that mechanically reduces the float and supports earnings per share. Meanwhile, 'Amrize: 3 Key Takeaways for Long-Term Investors' suggests the investment community is debating the company's long-term trajectory. The $1.3M in insider buying across this period sends a clear signal: management believes the stock is priced attractively. The challenge remains that 'attractive to management' and 'attractive entry for new investors at $41.63' are very different propositions.
Risk Assessment
PRIMARY RISK: The unbroken analyst target deterioration trend represents the highest-conviction risk signal — if targets continue declining (now at $44.30, down from $61.98 over the tracked period), the implied upside could turn negative before the thesis plays out. The revenue growth collapse from 8.6% to 2.2% is a material fundamental deterioration that may drive further target cuts. SECONDARY RISK: PEG expansion from 1.37x to 1.62x signals the market is repricing the stock's growth premium — continued EPS estimate revisions downward could compress the multiple further. MITIGATION: Conservative D/E of 0.40x and FCF of $1.08B provide a floor — this is not a distress situation. The stop at $34.50 (-17.1% from current) aligns with the lower end of the prior entry zone and represents strong technical support. For existing holders who entered the prior zone ($34.50–$37.50): continue to hold with the stop at $34.50, as the fundamentals have not deteriorated catastrophically and the pricing power data (aggregates +6.9%) is constructive. For new entrants: wait for a pullback to the $37.50–$39.50 zone before initiating, as the current $41.63 price offers only 6.4% to the analyst target with a 17% downside to the stop.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is AMRZ a halal stock?
No, Amrize AG (AMRZ) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for AMRZ?
Amrize AG (AMRZ) has a Plutrex AI rating of 65.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is AMRZ a good investment?
According to Plutrex AI, AMRZ has a Buy rating (65.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in AMRZ?
US stocks like AMRZ can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in AMRZ?
Plutrex AI identifies the main risks for AMRZ by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.